Multimodal Imaging Market: Market Size & Forecast 2026

Multimodal imaging refers to the integration of multiple diagnostic imaging technologies into single systems, most commonly combining anatomical imaging modalities like CT or MRI with functional imaging techniques such as PET or SPECT. This integration allows clinicians to overlay functional metabolic data onto detailed anatomical structures, improving diagnostic accuracy for oncology, cardiology, and neurology applications. The market encompasses hardware systems, software platforms, contrast agents, and associated IT infrastructure required for image fusion, processing, and clinical workflow management.

• •The market is projected to grow from approximately $4.6 billion in 2025 to between $7.6 billion and $8.2 billion by 2030-2035, reflecting sustained demand for hybrid imaging solutions
• •Multimodal systems command premium pricing compared to single-modality equipment, driving higher average selling prices and contributing to above-average market growth
• •The sector overlaps with the broader medical imaging market and the enterprise imaging IT market, which is itself projected to reach $4.12 billion by 2030 at a 12.2% CAGR

The primary driver of market expansion is the clinical superiority of fused imaging data, which improves diagnostic confidence and enables more precise treatment planning, particularly in oncology and neurological disorders. Technological miniaturization and reduced radiation dose requirements are making hybrid systems more accessible to smaller healthcare facilities. Additionally, the integration of artificial intelligence and machine learning algorithms is accelerating image reconstruction times, enhancing pattern recognition, and reducing the need for highly specialized radiologists, thereby expanding adoption in resource-constrained settings.

• •Rising global burden of cancer, cardiovascular disease, and neurodegenerative disorders is increasing demand for advanced diagnostic tools that can stage disease and monitor treatment response
• •Healthcare systems are increasingly focused on value-based care, where multimodal imaging's ability to reduce repeat scans and improve diagnostic accuracy supports cost containment goals
• •Advancements in detector technology, digital processing, and AI-assisted interpretation are lowering operational barriers and expanding the clinical applications of hybrid imaging systems

The market is typically segmented by modality combination, including PET/CT, SPECT/CT, PET/MRI, and emerging combinations, with PET/CT historically dominating due to its established clinical utility and broader installed base. By end user, hospitals and diagnostic imaging centers represent the largest segment, followed by research institutions and specialty clinics. Geographically, North America currently leads the market due to advanced healthcare infrastructure, favorable reimbursement policies, and high adoption of innovative medical technologies, while the Asia-Pacific region is expected to grow at the fastest rate driven by healthcare modernization, rising disposable incomes, and expanding diagnostic capabilities.

• •PET/CT systems represent the largest modality segment, though PET/MRI is gaining share due to superior soft-tissue contrast and reduced radiation exposure
• •Oncology applications account for the majority of multimodal imaging utilization, with growing adoption in cardiology and neurology segments
• •North America and Europe together account for the majority of market value, while Asia-Pacific, Latin America, and the Middle East represent the highest growth opportunities

Who are the notable companies in the industry?

The multimodal imaging market exhibits moderate to high consolidation, with a relatively small number of large, diversified manufacturers controlling the majority of global market share through extensive patent portfolios and established distribution networks. The competitive structure is characterized by vertically integrated producers that design and manufacture both imaging hardware and associated software platforms, alongside a smaller segment of specialty technology providers focused on specific components such as detectors, reconstruction algorithms, or AI-enabled analysis tools. Production relies on advanced semiconductor detector technologies, sophisticated magnetic and gradient coil systems, and proprietary image fusion algorithms, with manufacturing concentrated in regions with strong medical technology industrial bases.

• •The market is moderately consolidated with barriers to entry driven by high R&D costs, lengthy regulatory approval cycles, and the need for comprehensive service and support infrastructure
• •Leading producers maintain vertically integrated operations spanning hardware manufacturing, software development, and global service networks, while smaller competitors often specialize in niche technologies or regional markets
• •Manufacturing and primary R&D activity is concentrated in North America, Europe, and Japan, with emerging market players increasingly focused on software solutions and cost-optimized system variants

What are the recent trends and outlook?

The market is moving toward fully digital, AI-augmented imaging ecosystems where multimodal systems function as data-rich nodes within broader clinical workflows, enabling precision medicine approaches and longitudinal disease monitoring. Total imaging solutions incorporating radiotherapy guidance, theranostics integration, and real-time image fusion are emerging as the next generation of hybrid systems. Long-term growth will be sustained by continued technological convergence, the expansion of indications for hybrid imaging, and increasing healthcare investment in emerging economies.

• •AI and deep learning are being embedded directly into scanner hardware and reconstruction pipelines to reduce scan times, improve image quality, and automate quantitative analysis
• •Theranostic applications combining diagnostic imaging with targeted radionuclide therapy are creating new demand for integrated multimodal platforms capable of both imaging and treatment guidance
• •The broader AI in medical imaging market, valued at over $2 trillion in 2025, is expected to drive complementary innovation and create synergistic growth opportunities across the multimodal imaging ecosystem